Zheng Quan Zhi Xing·2025-09-04 16:21Core Viewpoint - Shenzhen Huatai Medical Devices Co., Ltd. is undergoing a significant equity change, with Shenzhen Mindray Technology Holdings Co., Ltd. increasing its stake through a block trade, acquiring 655,536 shares, which represents 0.46% of the total share capital of Huatai Medical [1][2]. Group 1: Company Overview - Company Name: Shenzhen Huatai Medical Devices Co., Ltd. [1] - Stock Listing: Shanghai Stock Exchange, Stock Code: 688617.SH [1] - Registered Address: Shenzhen, Nanshan District, High-tech Industrial Park [1] - Information Disclosure Obligor: Shenzhen Mindray Technology Holdings Co., Ltd. [1] Group 2: Equity Change Details - The equity change involves a block trade executed on the Shanghai Stock Exchange [1]. - The transaction date is set for September 2025 [1]. - The increase in shares is part of a larger agreement involving multiple parties, including various investment entities [1][2]. Group 3: Financial Overview of Mindray Technology - Total Assets as of December 31, 2024: 1,600,345.57 million RMB [9] - Total Equity as of December 31, 2024: 1,354,513.21 million RMB [9] - Operating Revenue for 2024: 618,157.41 million RMB [9] - Net Profit for 2024: 85,252.93 million RMB [9] Group 4: Related Parties - Consistent control structure exists between Shenzhen Mindray and its subsidiaries, with key figures being Li Xiting and Xu Hang [2][10]. - Zhuhai Tongsheng Investment Partnership, a related party, has also been involved in the equity change, holding a significant stake in Huatai Medical [10]. Group 5: Compliance and Legal Standing - Shenzhen Mindray has not faced any administrative or criminal penalties in the last five years [9][10]. - The company maintains a clean legal record with no significant civil litigation or arbitration cases [9][10].